Charlie Reighard, Mphil
Charlie Reighard is an experienced basic science and clinical researcher. His clinical background includes research in novel disease biomarkers, development of diagnostic assays for Alzheimer’s disease, and literature and database reviews for anesthesia-related toxicities. At Alkemi, he is responsible for clinical research, medical guideline strategy, literature review and clinical publication strategy. Mr. Reighard completed his BA in Neuroscience at Amherst College and a Master of Philosophy in Biochemistry at the University of Cambridge.